Clinical Data

Maze tumbles despite positive data for kidney disease drug

BioPharma Dive

Investors had reservations about data for a drug that could compete with a candidate from Vertex in APOL1-mediated kidney disease.

Clinical Data Rare Disease Read full story

pharminent March 25, 2026 (Last updated: March 26, 2026)

BioPharma Dive

Investors had reservations about data for a drug that could compete with a candidate from Vertex in APOL1-mediated kidney disease.

Clinical Data Rare Disease Read full story